文献速递心境障碍精神分裂症与精神病性障碍物质与行为成瘾

重性精神障碍多基因风险评分的稳定性和特异性低,限制其临床效用

Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility.
PubMed 文献 · Biol Psychiatry · 2025-03-18

该研究基于英国生物银行2006至2010年招募的502,534名37至73岁个体,对408,853名英国白人计算多基因风险评分(PRS),评估重性抑郁障碍、酒精使用障碍、精神分裂症和2型糖尿病不同PRS之间的一致性及识别高风险个体的准确性,发现PRS稳定性有限且所有PRS特异性低(50.7%–56.4%),结论认为当前PRS在精神病学中缺乏临床效用。

要点

  • 不同PRS间相关性从低到高不等(精神分裂症r=0.78;重性抑郁障碍rs=0.16–0.78;酒精使用障碍rs=0.13–0.90;2型糖尿病rs=0.29–0.77)。
  • 以一个PRS判定为高风险(前5%)的个体中,用另一个PRS仍判定为高风险的比例:精神分裂症47.7%、重性抑郁障碍9.5%–47.0%、酒精使用障碍8.3%–63.5%、2型糖尿病14.1%–45.2%。
  • 所有PRS特异性低(50.7%–56.4%);敏感性重性抑郁障碍66.1%–74.4%、酒精使用障碍72.3%–74.2%、2型糖尿病77.3%–96.3%、精神分裂症90.2%–93.3%。

核心结论

  • PRS稳定性和特异性有限,突显其当前在精神病学中缺乏临床效用。

研究设计与样本

  • 英国生物银行2006至2010年在英国招募502,534名37至73岁个体,对408,853名英国白人计算PRS。
  • 采用PRS连续收缩法(CS)计算重性抑郁障碍、酒精使用障碍和2型糖尿病各3种不同PRS,精神分裂症2种不同PRS。
  • 通过同种障碍不同PRS间相关性及持续判定为高风险(前5% PRS)的个体百分比衡量稳定性,用敏感性和特异性衡量效度。

主要发现

  • 不同PRS间相关性:精神分裂症r=0.78;重性抑郁障碍rs=0.16–0.78;酒精使用障碍rs=0.13–0.90;2型糖尿病rs=0.29–0.77。
  • 以一个PRS判定为高风险(前5%)的个体中,用另一个PRS仍判定为高风险的比例:精神分裂症47.7%,重性抑郁障碍9.5%–47.0%,酒精使用障碍8.3%–63.5%,2型糖尿病14.1%–45.2%。
  • PRS敏感性:重性抑郁障碍66.1%–74.4%,酒精使用障碍72.3%–74.2%,2型糖尿病77.3%–96.3%,精神分裂症90.2%–93.3%。
  • 所有PRS特异性低(50.7%–56.4%)。

关键数值与推荐

  • PRS稳定性以同种障碍不同PRS间相关性及持续判定为高风险(前5% PRS)的个体百分比衡量。
  • PRS效度以敏感性和特异性衡量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been little examination of the stability and validity of polygenic risk scores (PRSs), i.e., whether individuals identified as high risk for a disorder with one PRS are identified as high risk with another PRS and whether high-risk individuals have the disorder. METHODS: The UK Biobank recruited 502,534 individuals ages 37 to 73 years in the United Kingdom between 2006 and 2010. PRSs were calculated for 408,853 White British individuals. PRS continuous shrinkage (CS), which uses single nucleotide polymorphism effect sizes under CS, was used to calculate 3 different PRSs for major depressive disorder (MDD), alcohol use disorder (AUD), and type 2 diabetes (T2D) and 2 different PRSs for schizophrenia (SCZ). PRS stability was measured using correlations between different PRSs for the same disorder and the percentage of individuals consistently identified as high risk (top 5% PRS). Sensitivity and specificity were used to measure PRS validity. RESULTS: Correlations between PRSs ranged from low to high (SCZ: r = 0.78; MDD: rs = 0.16-0.78; AUD: rs = 0.13-0.90; T2D rs = 0.29-0.77). The percentage of individuals consistently identified as high risk (top 5% PRS) for SCZ with a different SCZ PRS was 47.7%, i.e., less than half of individuals identified as high risk with one PRS were identified as high risk with another PRS. Percentages of individuals consistently identified as high risk were 9.5% to 47.0% for MDD, 8.3% to 63.5% for AUD, and 14.1% to 45.2% for T2D. PRS sensitivity was moderate for MDD (66.1%-74.4%) and AUD (72.3%-74.2%), moderate/good for T2D (77.3%-96.3%), and good for SCZ (90.2%-93.3%). Specificity was low for all PRSs (50.7%-56.4%). CONCLUSIONS: Limited stability and specificity of PRSs highlight their current lack of clinical utility in psychiatry.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Mollon J, Schultz LM, Knowles EEM, et al. Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility. Biol Psychiatry. 2025. PMID: 40113122. doi:10.1016/j.biopsych.2025.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。